Paper Review Records
All Paper Review Records
22 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
258
days
Anthropometric traits, metabolic biomarkers, and pancreatic cancer risk: a causal mediation analysis in UK Biobank
Authors
Amina Amadou; Heinz Freisling; Benoit Mercoeur; Patricia Bohmann; Michael J. Stein; Hwayoung Noh; Alem Gebremariam; Anja M. Sedlmeier; Laia Peruchet-Noray; Quan Gan; Michael F. Leitzmann; Hansjörg Baurecht; Béatrice FerversShow moreShow less
Affiliations
1. Department of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France; 2. Inserm U1296 Radiations: Defense, Health, Environment, Lyon, France; 3. International Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France; 4. Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany; 5. Center for Translational Oncology, University Hospital Regensburg, Regensburg, GermanyShow moreShow less
343
days
TP53 mutation-biased CD8 + T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma
Authors
Xiaohe Su; Kaifeng Jin; Han Zeng; Zhaopei Liu; Lingkai Zhang; Yawei Ding; Jiaxing Sun; Yuzhen Wu; Hailong Liu; Yuan Chang; Le Xu; Weijuan Zhang; Zewei Wang; Yu Zhu; Jiejie XuShow moreShow less
Affiliations
1. Shanghai Urothelial Carcinoma Research Group (SUCRG), National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China; 2. Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China; 3. Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China; 4. Department of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 5. Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China; 6. Department of Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
78
days
A national survey of UK Family History services
Authors
Thomas J. E. Hubbard; Jon Coleman Reed; Sumohan Chatterjee; Helen Hanson; Ramsey CutressShow moreShow less
Affiliations
1. Faculty of Health and Life Sciences, University of Exeter, Exeter, UK; 2. Prevent Breast Cancer, Manchester, UK; 3. Manchester University Foundation NHS Trust, Manchester, UK; 4. University of Southampton, Southampton, UKShow moreShow less
105
days
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma
Authors
Joseph S. Baxter; Claudia Montiel Equihua; Jan J. Molenaar; Jamie Aye; Gianni Bisogno; Patricia Blanc; Willemijn Breunis; Julia Chisholm; Jacquelyn Crane; Sam Daems; Laura Danielson; Bram de Wilde; Adam D. Durbin; Felipe Galvez-Cancino; Patrizia Gasparini; Birgit Geoerger; Simone Graham; Bass Hassan; Mark E. Hatley; Delphine Heenen; Christine M. Heske; Simone Hettmer; Elizabeth Hookham; Peter Houghton; Pamela Kearns; Charles Keller; Javed Khan; Fiona Kinnis; David Langenau; Geffen Lass; Corinne Mary Linardic; Leo Mascarenhas; Michael T. Meister; Jonathan Metts; Véronique Minard-Colin; Sapna Oberoi; Daniela Palacios; Abbe Pannucci; Seema Patel; Sheena Patel; Silvia Pomella; Terry Rabbitts; Rossella Rota; Erin Rudzinski; Beat Schäfer; John Jack Shern; Karin Straathof; Rajkumar Venkatramani; Marco Wachtel; Sara Wakeling; Zoë Walters; Sam Warburton; Brenda Weigel; Andrew D. J. Pearson; David Jenkinson; Janet Shipley; Michela CasanovaShow moreShow less
Affiliations
1. LifeArc, London, UK; 2. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; 3. The University of Alabama at Birmingham, Birmingham, USA; 4. Department of Women’s and Children’s Health, University of Padova and Pediatric Hematology Oncology Unit, University Hospital of Padova, Padua, Italy; 5. Imagine for Margo, Paris, France; 6. University Children’s Hospital Zurich, Zürich, Switzerland; 7. The Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK; 8. Children’s Hospital of Philadelphia, Philadelphia, USA; 9. Waterland Private Equity Investments, Antwerp, Belgium; 10. I3h Institute, Université libre de Bruxelles, Brussels, Belgium; 11. Cancer Research UK, London, UK; 12. Ghent University Hospital, Gent, Belgium; 13. St Jude Children’s Research Hospital, Memphis, USA; 14. Laboratory of Immune-Regulation, Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 15. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy; 16. Gustave Roussy, Paris, France; 17. Sir William Dunn School of Pathology, University of Oxford, Oxford, UK; 18. KickCancer Foundation, Brussels, Belgium; 19. Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA; 20. Pediatrics I, Martin-Luther University Halle-Wittenberg, Halle, Germany; 21. UT Health San Antonio, San Antonio, USA; 22. College of Medicine and Health, University of Birmingham, Birmingham, UK; 23. Innovative Therapies for Children and Adolescents with Cancer (ITCC), Paris, France; 24. Children’s Cancer Therapy Development Institute, Hillsboro, USA; 25. Oncogenomics Section, Genetics Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, USA; 26. Massachusetts General Hospital - Charlestown Navy Yard (CNY) Campus, Charlestown, USA; 27. Department of Pediatrics, Duke University School of Medicine, LSRC, Durham, USA; 28. Cedars Sinai, Los Angeles, USA; 29. Johns Hopkins All Children’s Cancer & Blood Disorders Institute, Saint Petersburg, USA; 30. Max Rady College of Medicine, Pediatrics and Child Health, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada; 31. Institute for Systems Analysis and Computer Science “Antonio Ruberti” (IASI), National Research Council (CNR), Rome, Italy; 32. Alice’s Arc, New York City, USA; 33. Cancer Research Horizons, London, UK; 34. Bambino Gesu’ Children’s Hospital, IRCCS, Rome, Italy; 35. The Institute of Cancer Research, Brookes Lawley Building, Centre for Cancer Drug Discovery, Sutton, UK; 36. Indiana University School of Medicine, Indianapolis, USA; 37. Universitäts-Kinderspital Zürich, Eleonorenstiftung, Zürich, Switzerland; 38. Cancer Research, National Cancer Institute, Bethesda, USA; 39. University College London Cancer Institute, Great Ormond Street Biomedical Research Centre, London, UK; 40. Texas Children’s Hospital, Houston, USA; 41. Alice’s Ark, Children’s Cancer Charity, Sevenoaks, UK; 42. Southampton General Hospital, University of Southampton, Southampton, UK; 43. The Institute of Cancer Research, London, UKShow moreShow less
44
days
Risk-based breast cancer screening
Authors
Stig Egil BojesenShow moreShow less
Affiliations
1. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2. Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev Gentofte, Copenhagen, DenmarkShow moreShow less
137
days
Next-generation models for lymphoid malignancies: the rise of 3D culture systems in translational hematology
Authors
Narimène Houmera; Laurent Genestier; Sarah HuetShow moreShow less
Affiliations
1. Team Lymphoma Immuno-Biology, Centre International de Recherche en Infectiologie, Lyon, France; 2. Institut des Sciences Pharmaceutiques et Biologiques, Université Claude Bernard Lyon 1, Lyon, France; 3. Service d’hématologie biologique, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, FranceShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days